注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Gensight Biologics SA是一家法国的生物制药公司。该公司开发并商业化基于基因疗法的视网膜变性疾病的治疗方法。它开发了一些方法来防止在选定的病理条件下视网膜变性并恢复视力低下或失明患者的视力。该公司主要计划开发一种用于Leber遗传性视神经病变(LHON)的基因替代疗法和一种用于色素性视网膜炎(RP)的光遗传疗法。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Michael Stephen Wyzga | 66 | 2013 | Independent Chairman of the Board |
Jose-Alain Sahel | - | 2012 | Scientific Founder, Vice Chairman of Scientific Advisory Board & Board Observer |
Botond Roska | - | 2012 | Scientific Founder & Chairman of Scientific Advisory Board |
Serge Picaud | - | 2012 | Scientific Founder & Member of Scientific Advisory Board |
Constance L. Cepko | - | 2012 | Scientific Founder & Member of Scientific Advisory Board |
Luk H. Vandenberghe | - | 2012 | Scientific Founder & Member of Scientific Advisory Board |
Cédric Moreau | - | 2019 | Representative Director |
Maritza C. McIntyre | - | 2019 | Independent Director |
Laurence Rodriguez | - | 2023 | CEO & Director |
Simone Seiter | 57 | 2017 | Independent Director |
Ernst Bamberg | - | 2012 | Member of Scientific Advisory Board |
Elsy Lisa Boglioli | 42 | 2020 | Independent Director |
Francoise de Craecker | 61 | 2021 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核